Overview
Patients of scientific interest who have provided a commercial sample to LabCorp or one of its' affiliates will have their de-identified remnant samples and/or data used for research and development. Other commercial patients will be followed up on after informed consent is obtained.
Description
Arm 1 - Remnant commercial samples and data that has been de-identified of personal health information in compliance with HIPAA may be used for R&D studies or population-based analysis by LabCorp or affiliates.
Arm 2 - Collection of samples and/or data from commercial test patients requiring follow-up or from subjects of scientific interest after informed consent is obtained.
Eligibility
Inclusion Criteria:
- Arm 1
- All samples and data are de-identified and HIPAA compliant
- Arm 2
- Subject is of scientific interest to the Sponsor or treating physician
- Subject provides written informed consent and has a clinical sample and/or supporting clinical data collected.
Exclusion Criteria:
- Arm 1
- Subject is from a US state or a country where local law restricts the use of de-identified data and/or remnants of specimens for research and/or development
- Arm 2
- Any medical or mental condition that would interfere with the subjects' ability to willingly give written informed consent